Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1920 publications

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Journal: Cardiology in review
Published: November 06, 2025

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Journal: American journal of physiology. Heart and circulatory physiology
Published: October 16, 2025

Dual Challenge: Managing Complicated Diphtheria in a Child With Acute Myeloid Leukemia.

Dual Challenge: Managing Complicated Diphtheria in a Child With Acute Myeloid Leukemia.

Journal: Cureus
Published: October 12, 2025

Ivabradine as a Cardio-Protective Agent Against Anthracycline-Induced Cardiotoxicity: A Narrative Review.

Ivabradine as a Cardio-Protective Agent Against Anthracycline-Induced Cardiotoxicity: A Narrative Review.

Journal: Cardiovascular drugs and therapy
Published: October 11, 2025

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

Journal: Redox biology
Published: October 06, 2025

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

Journal: International heart journal
Published: October 01, 2025

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 29, 2025

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Journal: HemaSphere
Published: September 25, 2025

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.

Journal: Gene
Published: September 15, 2025

Effect of astragaloside IV dripping pills on mice with dilated cardiomyopathy.

Effect of astragaloside IV dripping pills on mice with dilated cardiomyopathy.

Journal: Drug development and industrial pharmacy
Published: September 10, 2025

Early-Onset Chronic Drug-Induced Cardiomyopathy in a Pediatric Patient With Ewing Sarcoma.

Early-Onset Chronic Drug-Induced Cardiomyopathy in a Pediatric Patient With Ewing Sarcoma.

Journal: Cureus
Published: August 22, 2025

Inhibition of Spi1 alleviates doxorubicin-induced myocardial injury by suppressing YTHDF2-mediated PI3K/AKT/mTOR signaling.

Inhibition of Spi1 alleviates doxorubicin-induced myocardial injury by suppressing YTHDF2-mediated PI3K/AKT/mTOR signaling.

Journal: International immunopharmacology
Published: August 18, 2025
Showing 1-12 of 1,920

Last Updated: 01/07/2026